[BioSpectator] CKD Pharm Nafabelltan gains approval for Phase 3 COVID-19 Clinical Trial in Ukraine
2021-09-30
BioSpectator (2021.9.30)
CKD Pharm Nafabelltan gains approval for Phase 3 COVID-19 Clinical Trial in Ukraine
CKD Pharm Nafabelltan gains approval for Phase 3 COVID-19 Clinical Trial in Ukraine